Crewe Advisors’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3K Buy
366
+198
+118% +$7.13K ﹤0.01% 654
2026
Q1
$5.41K Sell
168
-138
-45% -$4.9K ﹤0.01% 765
2025
Q4
$11K Buy
306
+32
+12% +$1.18K ﹤0.01% 604
2025
Q3
$8.62K Buy
+274
New +$9.84K ﹤0.01% 656
2024
Q3
Sell
-256
Closed -$11.7K 987
2024
Q2
$11.7K Buy
256
+192
+300% +$9.05K ﹤0.01% 657
2024
Q1
$3.33K Buy
+64
New +$2.81K ﹤0.01% 802

Other funds holding VCEL

Crewe Advisors's VCEL Position: Q2 2026 in Review

Crewe Advisors increased its Vericel Corp (VCEL) stake by 118% in Q2 2026, buying an estimated $7.13K and bringing the position to 366 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Crewe Advisors first reported a position in VCEL in Q1 2024 and has held it in 6 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Crewe Advisors held 366 shares of Vericel Corp worth $16.3K as of Q2 2026.
  • Crewe Advisors bought 198 Vericel Corp shares in Q2 2026, an estimated $7.13K.
  • Vericel Corp made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #654 holding.
  • Crewe Advisors first reported a position in Vericel Corp in Q1 2024 and has held it in 6 quarters since.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.